The ‘Exclusive Sale Rights Policy’for generics that succeeded in patent challenges has been completed by almost 90%.

In this speed, it is expected that the policy will be decided on the standing committee of the Bill Examination Subcommittee and be introduced in the general meeting on the 24^{th. ...}